Globalization Bill Should Link IT Systems Across Import Safety – Stakeholders
This article was originally published in The Tan Sheet
Executive Summary
Draft legislation to reform FDA's import safety oversight fails to address the agency's urgent need to improve the IT connections between its own divisions as well as with other agencies, drug industry stakeholders say
You may also be interested in...
Globalization Act’s Drug Safety Provisions Look Harmful For Industry
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys
Globalization Act’s Drug Safety Provisions Look Harmful For Industry
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys
Globalization Act’s Drug Safety Provisions Look Harmful For Industry
The FDA Globalization Act could be devastating to the drug industry while not creating the safety improvements that Congress expects, according to former FDA attorneys